Fact CheckerSign in

NCT05003414Active, not recruiting

The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study

A Prospective, Multicentre, International, Post-marketing, Longitudinal, Observational Cohort Study to Monitor the Performances of GMK Sphere Cementless Knee Prosthesis

Source: ClinicalTrials.gov · Last updated 29 Sept 2025

Brief summary (registry, in English)

This is a Post-Marketing Surveillance study of GMK Sphere cementless knee prosthesis.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
6 Aug 2021
Start date
14 Jan 2020
Primary completion date
31 Jan 2030
Lead sponsor
Medacta International SA
NCT number
NCT05003414

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 14 Jan 2020 to the primary completion date, 31 Jan 2030
  • 5 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Progressive local or systemic infection
  • Muscular loss, neuromuscular disease or vascular deficiency of the affected limb, making the operation unjustifiable

Other

  • Severe instability secondary to advance destruction of condralar structures or loss of integrity of the medial or lateral ligament
  • Those whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems
  • Patient whose BMI exceeds 40
  • Any case not described in the inclusion criteria

Who the study is looking for

  • A disabled or severely disabled joint as a result of arthritis, traumatic arthritis, rheumatoid arthritis, poly-arthritis or avascular necrosis
  • Patients between the age of 18 and 80 at the time of consent
  • Listed for total knee replacement surgery.
  • Patients who are willing and able to give informed written consent

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hôpital de La Tour
Coordinator of this site? Confirm its status
MeyrinSwitzerlandUnknown status
Clinique Saint Vincent de Paul
Coordinator of this site? Confirm its status
BourgoinFranceUnknown status
Clinique du Parc
Coordinator of this site? Confirm its status
CaenFranceUnknown status
Hôpitaux Civils de Colmar
Coordinator of this site? Confirm its status
ColmarFranceUnknown status
Clinique des Acacias
Coordinator of this site? Confirm its status
CucqFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.